|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses: | |
| Research and development expenses, net: | |
| Research and development expenses | |
| Research and development expenses, net | |
| General and administrative expenses | |
| Operating profit (loss) | |
| Financial income (expense), net: | |
| Change in fair value of convertible notes | |
| Changes in fair value of warrant liability | |
| Other financing expense, net | |
| Financial income (expense), net | |
| Net income (loss) and comprehensive income (loss) | |
| Basic net income (loss) per share | |
| Dilutednet income (loss) per share | |
| Weighted average number of ordinary shares used in computing basic | |
| Weighted average number of ordinary shares used in computing diluted |
Loading...
